5,000+ patients guided through treatment in Delhi NCREvery case read by a US board-certified physicianWritten opinion with costs within 48 hoursNABH and JCI accredited hospitals onlyArabic, English, Russian and Bengali spokenOur fees are published — hospitals pay us, not youMedical visa invitation letters for eight countries
TIB HIND

Sudden back pain with leg weakness or difficulty passing urine is an emergency. Go to hospital now. This may be spinal cord compression, which is measured in hours. Also seek urgent care for confusion with severe thirst, or fever.

Home  /  Treatments  /  Bone marrow transplant  /  Multiple myeloma

Multiple myeloma

A cancer of plasma cells in the bone marrow. It weakens bones, impairs the kidneys, causes anaemia and raises calcium — and it is now treated as a long-term condition rather than a short illness.

Myeloma is where autologous transplant is standard rather than exceptional. Because the stem cells are the patient's own, it is a considerably safer procedure than a donor transplant, and it remains a routine part of treatment for suitable patients.

Transplant type
Autologous
Your own cells — no rejection, no graft-versus-host
Standard sequence
Induction, transplant, maintenance
Rather than transplant alone
Watch for
Cord compression
Back pain with leg weakness is an emergency
Time in India
2 to 3 months
For collection, transplant and recovery
The condition

What multiple myeloma is

Plasma cells normally make antibodies. In myeloma one clone of plasma cells multiplies abnormally in the bone marrow, producing large quantities of a single useless antibody — the paraprotein — while crowding out normal blood production.

The consequences form a recognisable pattern, often remembered as CRAB: raised calcium, renal impairment, anaemia, and bone lesions. The bone disease is characteristic — the abnormal cells activate the cells that break down bone, producing punched-out lesions, fractures through weakened vertebrae, and severe pain.

Kidney impairment is common and partly reversible if treated promptly, caused by light chains from the paraprotein damaging the tubules, sometimes compounded by dehydration, high calcium and anti-inflammatory painkillers.

Myeloma is not currently curable in most patients, but treatment has changed enormously. Sequences of highly effective drug combinations, autologous transplant in suitable patients, and maintenance therapy have turned it into a condition many people live with for many years.

Symptoms

Symptoms and warning signs

Common symptoms
  • Persistent back or rib pain, often worse on movement
  • Fractures from minor injury, particularly of the spine
  • Fatigue and breathlessness from anaemia
  • Frequent infections, particularly chest infections
  • Excessive thirst, confusion and constipation from high calcium
  • Frothy urine or reduced urine output
  • Unexplained weight loss and night sweats
Warning signs of an emergency
  • Back pain with leg weakness, numbness or difficulty passing urine
  • Confusion with severe thirst — possible very high calcium
  • Fever with a low white cell count
  • Sudden severe breathlessness
  • Markedly reduced urine output
  • Severe bone pain after minor injury — possible fracture

Back pain with leg weakness is a surgical emergency

Myeloma weakens the vertebrae, and a collapsing vertebra or a mass of plasma cells can press on the spinal cord. The warning signs are new or worsening back pain with weakness in the legs, numbness in a band around the trunk, or difficulty passing urine. Once the cord is damaged the deficit is frequently permanent, and treatment is measured in hours. This needs an urgent MRI and immediate steroids and radiotherapy or surgery — at the nearest hospital, not after arranging travel.

Diagnosis

How it is diagnosed

Blood and urine protein studies, plus imaging of the whole skeleton.

Initial tests

  • Serum protein electrophoresis and immunofixation — identifies and quantifies the paraprotein
  • Serum free light chain assay — particularly important where no paraprotein is detectable in blood
  • Full blood count, calcium, kidney function and albumin
  • Bone marrow aspirate and biopsy — measures the proportion of plasma cells and provides cytogenetics

The deciding tests

  • Whole body low-dose CT, MRI or PET-CT — modern imaging has replaced the old skeletal survey and detects lesions far earlier
  • Cytogenetics by FISH — identifies high-risk abnormalities that change treatment intensity and prognosis
  • Beta-2 microglobulin and LDH — used with albumin for staging
  • 24-hour urine protein — for light chains damaging the kidney

Send the cytogenetics as well as the diagnosis

Cytogenetic abnormalities identified by FISH on the marrow sample separate standard-risk from high-risk myeloma, and that distinction affects treatment intensity, the role of transplant and the realistic outlook. Send the marrow report with cytogenetics, the paraprotein and light chain levels, calcium and kidney function, and the imaging report. Also send the details of any treatment already given and the response to it.

Options

Treatment options

Treatment is a sequence rather than a single intervention.

Step one

Induction therapy

A combination of drugs — typically a proteasome inhibitor, an immunomodulatory drug and a steroid, increasingly with an antibody added — given over several months to reduce the disease substantially before transplant. Much of this can be given near your home once the regimen is set.

Usually appropriate whenFirst treatment for essentially every newly diagnosed patient fit for active therapy.
Step two

Autologous stem cell transplant

Your own stem cells are collected, high-dose chemotherapy clears the marrow, and the cells are returned. Because they are your own there is no rejection and no graft-versus-host disease, making this far less hazardous than a donor transplant. It deepens the response and lengthens the time before the disease returns.

Usually appropriate whenPatients fit enough for high-dose therapy, after a good response to induction.
Step three

Maintenance therapy

Continuing a single drug at low dose after transplant, usually for years, to delay relapse. It is taken at home and is one of the clearest advances in myeloma management over the past decade.

Usually appropriate whenAfter transplant, and in many patients after induction where transplant is not performed.
Alongside

Bone, kidney and infection protection

Bisphosphonates or denosumab to protect the skeleton and reduce fractures, radiotherapy for painful lesions or cord compression, surgery to stabilise a threatened bone, careful attention to hydration and avoidance of anti-inflammatory painkillers, and vaccination and prompt treatment of infection.

Usually appropriate whenFrom diagnosis, for every patient. This part is frequently under-managed.
The decision

How the choice is made

Fitness for high-dose therapy

Age matters less than general fitness and organ function. Many patients in their sixties and seventies are suitable.

Cytogenetic risk

High-risk abnormalities shift the treatment towards more intensive and more prolonged regimens.

Kidney function

Significant kidney impairment affects drug choice and doses, and treating the myeloma promptly is what recovers kidney function.

Much of myeloma treatment is drug therapy given over months, and most of it can be given near your home. What is genuinely worth travelling for is the transplant itself and a properly constructed plan.

Urgency

How urgent is your case

Usually safe to plan travel
  • Stable on induction therapy
  • Good response, planning stem cell collection
  • No fever or neurological symptoms
  • Calcium and kidney function controlled
Needs local assessment before travel
  • Back pain with leg weakness or bladder disturbance
  • Confusion with high calcium
  • Fever during chemotherapy
  • Rapidly worsening kidney function
  • Severe breathlessness or fracture

We will tell you which column you are in

Spinal cord compression and very high calcium are emergencies treated where you are, immediately. Both are common in myeloma and both are frequently recognised late.

Next step

What to send us

Photographs taken on your phone are fine. Reports in Arabic, Russian or Bengali are fine — we translate them ourselves.

Most useful

  • Bone marrow report with cytogenetics
  • Serum protein electrophoresis and free light chain results
  • Calcium, kidney function and full blood count
  • Whole body imaging report

Also helpful

  • Details of treatment already given and the response
  • Beta-2 microglobulin and albumin for staging
  • MRI of the spine if back pain is present
  • Your age and general fitness
Questions

Questions patients ask

Your own stem cells are collected from the blood, stored, and returned after high-dose chemotherapy has cleared the marrow. Because the cells are your own there is no rejection and no graft-versus-host disease, which makes it considerably safer than a donor transplant. It is a standard part of myeloma treatment rather than a last resort.

Probably not. Fitness matters far more than the number, and many patients in their sixties and seventies undergo autologous transplant successfully. The assessment looks at heart, lung and kidney function and general performance status. Send your reports and we will give you an honest view rather than an age-based rule.

In most patients it is not currently cured, but it is now treated as a long-term condition. Sequences of highly effective drugs, transplant and maintenance therapy have extended survival substantially, and many patients live for many years with good quality of life. A small proportion achieve very durable remissions.

No. Induction therapy over several months can usually be given near your home once the regimen is set, and maintenance is tablets taken at home. What is worth travelling for is stem cell collection and the transplant itself, plus a properly constructed treatment plan. We will map out which parts need to be here.

Myeloma activates the cells that break down bone, producing weakened areas and fractures, particularly through the vertebrae. Pain control, bisphosphonates to protect the skeleton, radiotherapy to painful lesions and sometimes surgical stabilisation are all part of treatment. New back pain with leg weakness is an emergency and needs immediate assessment.

Frequently, at least partially, if the myeloma is treated promptly. Kidney damage is largely caused by light chains from the paraprotein, so reducing the paraprotein quickly is the treatment. Good hydration and avoiding anti-inflammatory painkillers and contrast scans where possible also matter considerably.

Contact

Send us your reports

Send the bone marrow report with cytogenetics, your paraprotein and light chain levels, and kidney function. Tell us what treatment has already been given and how well it worked.

Your reports go directly to our medical team. We do not share your records with hospitals until you tell us to.

WhatsApp +91 83035 86344  ·  Phone +91 83035 86344  ·  Email tibhind@gmail.com

Coordinators available 9:00–20:00 IST. We speak Arabic, English, Russian and Bengali.